Medicenna Presentation Q4 2022 Investor Presentation With Ceo Fahar Merchant Phd

Medicenna Presentation Q4 2022 Investor Presentation with CEO Fahar Merchant PhD

Stock Therapy with Penny Queen

CEO Talks with Fahar Merchant, CEO & President of Medicenna Therapeutics Inc.

FocusLearningToronto

Medicenna Therapeutics - Corporate Update by CEO, Fahar Merchant and CFO, Elizabeth Williams

San Diego Torrey Hills Capital

Medicenna Investor Update

Stock Therapy with Penny Queen

Medicenna Intro Interview Plus Impressive Cancer Treatment Data

Stock Therapy with Penny Queen

Fahar Merchant, President and CEO, Medicenna Therapeutics

The View From The C-Suite

Fahar Merchant, President and CEO of Medicenna: Amendment Means Clinical Trial Changes

Medicenna Therapeutics (TSXV: MDNA) CEO: Our Drug Has Potential for Phase 2 Approval

🔴 Medicenna Therapeutics Corp MDNA Stock Trading Facts 🔴

Stuff About Stocks

Looking at cancer as a species not a disease - Medicenna Therapeutics Corp. | Healthtech Insights

AskAVC #4 - Secrets to a successful investor presentation (based on 20 years of experience!)

Medicenna Therapeutics opens TSX Venture Exchange, May 25, 2017

Dr. Fahar Merchant Discusses a Treatment to Combat Glioblastoma

Medicenna Therapeutics Corp. @ Sachs_OIF

Minister McGrath launches the Public Service Innovation Fund 2022

Better Public Services Ireland

MLconf Online 2020: Voice Assistants in Healthcare by Galina Grunin

Integrated Health Care Data: Amber Meranda, Vice President, Clinical Client Services, Capital Rx

The Conference Board

32nd Annual A4M Conference with CEO/Founder of ENERGYbits Dr. Catharine Arnston

FASB Revenue Recognition for Healthcare: Webcast for Investors

FASB - Financial Accounting Standards Board